The head of UNAIDS, Winnie Byanyima, has urged the United States to reconsider its decision to withdraw HIV/AIDS funding for South Africa, warning that the move could put millions of vulnerable people at risk and potentially cost lives. Speaking ahead of a high-level United Nations conference on HIV/AIDS, Byanyima expressed concern over the impact of the planned reduction in support from the President’s Emergency Plan for AIDS Relief (PEPFAR), a key program in the global fight against HIV/AIDS.
According to the U.S. State Department, Washington has decided to begin a phased drawdown of PEPFAR funding in South Africa, citing the country’s failure to meet certain policy expectations set by the administration. The department stated that PEPFAR was never intended to be a permanent funding source and emphasized that South Africa, as a middle-income country, has the capacity to finance its own healthcare programs.
Recent reports suggest the decision may also be linked to broader diplomatic disagreements between the two countries, including concerns over South Africa’s relationship with Iran and domestic policy issues. However, Byanyima stressed that withdrawing HIV funding could have severe humanitarian consequences.
South Africa has the world’s largest population of people living with HIV, with approximately 8 million infected individuals. While the country funds its own HIV medication programs, PEPFAR has historically contributed more than $400 million annually and supported the salaries of around 15,000 healthcare workers. The program has accounted for roughly 17% of South Africa’s HIV response funding.
Byanyima also warned that broader cuts to global development assistance are threatening decades of progress in HIV prevention and treatment. UNAIDS data show that more than 32 million of the nearly 40 million people living with HIV worldwide are receiving treatment. However, around 9 million still lack access to care, while 1.2 million new infections were recorded last year.
The UNAIDS chief said early signs of disruption are already emerging, including a 22% decline in HIV testing in high-burden countries and significant reductions in condom distribution. She cautioned that these setbacks could reverse years of progress and jeopardize the global goal of ending AIDS as a public health threat by 2030.
Calling for a carefully managed transition rather than abrupt funding cuts, Byanyima urged donor nations to maintain support for life-saving HIV programs. She emphasized that reducing funding without adequate planning risks increasing HIV infections, undermining treatment access, and reversing hard-won gains in the global fight against AIDS.


White House Seeks $1.4 Billion to Combat Growing Ebola Outbreak
US Caribbean Vessel Strike Kills Three
France Battles Mediterranean Wildfires as Heatwave Fuels Fire Risk
Trump Open to Chinese Automakers Building Cars in US
Trump Administration Bars U.S. Travelers From Congo Flights Amid Ebola Outbreak
Russian Drone Strikes Hit Ukraine-Moldova Border, Kyiv and Sumy
Trump’s Iran War Draws ‘Forever War’ Comparisons
U.S. Issues Cuba Health Alert as Illnesses Rise
Alcohol is one of the most dangerous drugs, yet its presence is ubiquitous in social settings and celebrations
Trump Promises $5,000 Dividend if Republicans Win Midterms
Novartis Shares Plunge After Muscle Drug Fails Phase III Trial
Moderna Short Sellers Hit With $4.8 Billion Loss as Stock Soars
Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback
France Keeps Top Health Alert as Officials Brace for Another Heatwave
Trump Advisers Warn Iran War Could Last Until 2029
Eli Lilly Eyes AtaiBeckley Acquisition to Expand Psychedelic Mental Health Pipeline
AstraZeneca Halts Phase III Volrustomig Lung Cancer Trial After Efficacy Setback 



